NatureCellLtd Past Earnings Performance
Past criteria checks 0/6
NatureCellLtd's earnings have been declining at an average annual rate of -37.5%, while the Biotechs industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 8.9% per year.
Key information
-37.5%
Earnings growth rate
-36.7%
EPS growth rate
| Biotechs Industry Growth | 11.7% |
| Revenue growth rate | -8.9% |
| Return on equity | -18.6% |
| Net Margin | -59.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How NatureCellLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 19,351 | -11,438 | 14,999 | 2,221 |
| 30 Sep 23 | 22,257 | -2,795 | 11,627 | 1,920 |
| 30 Jun 23 | 23,628 | -5,420 | 13,485 | 1,829 |
| 31 Mar 23 | 22,677 | -8,777 | 14,749 | 1,395 |
| 31 Dec 22 | 21,252 | -8,316 | 13,435 | 1,577 |
| 31 Dec 21 | 20,354 | -30,014 | 15,003 | 1,473 |
| 30 Sep 13 | 27,876 | -4,155 | 2,625 | 0 |
| 30 Jun 13 | 28,615 | -3,872 | 2,834 | 0 |
Quality Earnings: A007390 is currently unprofitable.
Growing Profit Margin: A007390 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A007390's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare A007390's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A007390 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (28.8%).
Return on Equity
High ROE: A007390 has a negative Return on Equity (-18.62%), as it is currently unprofitable.